Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study

Area of Science:

• Genetics
• Neuroscience
• Immunology

Background:

• Investigates potential causal relationships between 91 inflammatory markers and six neuropsychiatric disorders.
• Includes Alzheimer's disease (AD), multiple sclerosis (MS), Parkinson's disease (PD), anxiety disorders (ANX), depressive disorders (DEP), and unexplained encephalopathy (UE).

Purpose of the Study:

• To determine if specific inflammatory markers causally influence the risk of developing neuropsychiatric disorders.
• To explore bidirectional relationships, examining if these disorders affect inflammatory marker levels.

Main Methods:

• Employs a two-sample, two-way Mendelian randomization framework.
• Utilizes the inverse variance weighting method and integrates genome-wide association study statistics.
• Performs sensitivity analyses using MR-Egger and weighted median test for robustness.

Main Results:

• Identifies 14 systemic inflammatory modulators potentially causally linked to neuropsychiatric disorders.
• Specific associations found for Alzheimer's disease (5 markers), anxiety disorders (8 markers), depressive disorders (6 markers), and unexplained encephalopathy (1 marker).
• Suggests 33 systemic inflammatory factors may be modulated by neuropsychiatric conditions, with varying numbers of factors affected by each disorder.

Conclusions:

• Provides evidence for causal links between specific inflammatory markers and certain neuropsychiatric disorders.
• Highlights the need for further research into inflammatory associations with Parkinson's disease and multiple sclerosis.
• Suggests a complex interplay where inflammation influences neuropsychiatric conditions and vice versa.